Evidence map›Paper›PMID 20847986›Full record

ArticleThe Canadian journal of cardiology

Canadian efforts to prevent and control hypertension.

Norman R C Campbell, Guanmin Chen

Open access · greenAbstract read
In one paragraph

Article in The Canadian journal of cardiology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. [Control of arterial hypertension: a pending issueControle da hipertensão arterial: um assunto inacabado].Revista panamericana de salud publica = Pan American journal of public health · 2022
    Article
  3. HEARTS in the Americas: innovations for improving hypertension and cardiovascular disease risk management in primary care.Revista panamericana de salud publica = Pan American journal of public health · 2022
    Article
  4. Appraisal of the Knowledge of Hypertensive Patients Regarding Blood Pressure Control and Comorbidities: Results of a French Regional Survey.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2016
    Observational
  5. On the occasion of world hypertension day 2014: A nephrology point of view.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2014
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. 2010 Canadian Hypertension Education Program recommendations: An annual update.Canadian family physician Medecin de famille canadien · 2010
    Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Norman R C CampbellDepartment of Medicine, Lubin Cardiovascular Institute of Alberta, University of Calgary, Alberta, Calgary, Canada. ncampbel@ucalgary.ca
Guanmin Chen
Libin Cardiovascular Institute of Alberta · CA

Funding

Canadian Institutes of Health Research
6 · The paper itself

Abstract

Suboptimum blood pressure is estimated to be the leading risk factor for death worldwide and is associated with 13.5% of deaths globally. The clinical diagnosis of hypertension affects one in four adults globally and is expected to increase by 60% between 2000 and 2025. Clearly, global efforts to prevent and control hypertension are important health issues. While Canada had a prevalence of hypertension similar to that of the United States in the early 1990 s, the treatment and control rate was only 13% compared with 25% in the United States. A national strategic plan was developed, and a coalition of organizations and health care professional and scientist volunteers actively implemented parts of the strategy. Specific initiatives that have evolved include the development of hypertension knowledge translation programs for health professionals, the public and people with hypertension, an outcomes research program to assess the impact of hypertension and guide national-, regional- and community-based knowledge translation interventions, and a program to reduce the prevalence of hypertension by decreasing sodium additives in food. These initiatives have relied on the active involvement of health care professional volunteers, health care professional and scientific organizations and various government departments. There have been large increases in the diagnosis and treatment of hypertension, with corresponding reductions in cardiovascular disease and total mortality associated with the start of the hypertension initiatives. As a result, Canada is becoming recognized as a world leader in the prevention, treatment and control of hypertension.

Indexed as

CanadaDieteticsHealth EducationHealth PolicyHeart DiseasesHumansHypertensionIncidenceNutrition TherapyPrevalenceRisk Factors

Identifiers

PMID20847986
PMCPMC2949984
OpenAlexW2041130068

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.